-
Pfizer/BioNTech say that the updated Covid-19 booster protects against Omicron subvariants.
Pfizer CEO Albert Bourla said that he hopes the US’ new COVID-19 vaccine booster will encourage people to seek it. “As we head into…holiday season, we hope these updated data will encourage people to seek out…COVID-19 bivalent booster as soon as they are eligible,” Bourla added. Pfizer and BioNTech are developing a COVID-19 vaccine that…
-
After the debut of their pandemic vaccine, it’s getting started.
Moderna is in advanced talks to buy an experimental vaccine developed by BioNTech. Moderna and BioNTech said that they have agreed to combine their efforts to develop a vaccine against multiple Viruses, including Marburg and COVID-19. Moderna said it plans to begin human trials of the vaccine by the end of this year, adding it…